Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Cancer Immunology Research
|
May 5, 2025
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
Shuling Han, Luying Cui, Bojun Wang, et al.
Oncogene
|
December 26, 2024
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer
Yuanyu Liao, Rui Yang, Bojun Wang, et al.
Cancer Letters
|
July 24, 2025
Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response
Shuling Han, Zhuo Chen, Chang Hong, et al.
Cell Reports. Medicine
|
December 17, 2025
Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer
Bojun Wang, Yingjue Li, Mengde Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 31, 2024
TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic Acid Metabolism
Xiaona Fan, Yisheng Dai, Chuanfeng Mo, et al.
Cancer Research
|
December 9, 2024
Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
Luying Cui, Ruiqi Liu, Shuling Han, et al.
Cancer Letters
|
February 19, 2022
HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis
Yang Yao, Chao Liu, Bojun Wang, et al.
Journal for Immunotherapy of Cancer
|
January 19, 2021
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu, Ruiqi Liu, Bojun Wang, et al.
Clinical Science (London, England : 1979)
|
February 21, 2019
STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer
Chao Liu, Jiaqi Shi, Qingwei Li, et al.
Clinical and Translational Medicine
|
May 28, 2024
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer
Xin Guan, Ruiqi Liu, Bojun Wang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Cancer Immunology Research
|
May 5, 2025
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
Shuling Han, Luying Cui, Bojun Wang, et al.
Oncogene
|
December 26, 2024
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer
Yuanyu Liao, Rui Yang, Bojun Wang, et al.
Cancer Letters
|
July 24, 2025
Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response
Shuling Han, Zhuo Chen, Chang Hong, et al.
Cell Reports. Medicine
|
December 17, 2025
Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer
Bojun Wang, Yingjue Li, Mengde Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 31, 2024
TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1-Mediated Arachidonic Acid Metabolism
Xiaona Fan, Yisheng Dai, Chuanfeng Mo, et al.
Cancer Research
|
December 9, 2024
Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer
Luying Cui, Ruiqi Liu, Shuling Han, et al.
Cancer Letters
|
February 19, 2022
HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis
Yang Yao, Chao Liu, Bojun Wang, et al.
Journal for Immunotherapy of Cancer
|
January 19, 2021
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu, Ruiqi Liu, Bojun Wang, et al.
Clinical Science (London, England : 1979)
|
February 21, 2019
STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer
Chao Liu, Jiaqi Shi, Qingwei Li, et al.
Clinical and Translational Medicine
|
May 28, 2024
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer
Xin Guan, Ruiqi Liu, Bojun Wang, et al.
Page
of 6